Structure Therapeutics (GPCR) Treasury Shares (2022 - 2025)

Structure Therapeutics' Treasury Shares history runs 4 years deep, the most recent figure standing at $4.3 million for Q4 2025.

• In Q4 2025, Treasury Shares rose 308.37% year-over-year to $4.3 million; the TTM figure through Dec 2025 stood at $4.3 million (up 308.37% YoY), while the FY2025 annual figure was $4.3 million, up 308.37% from the prior year.
• Treasury Shares was $4.3 million for Q4 2025 at Structure Therapeutics, up from $1.1 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $4.3 million in Q4 2025 to a low of $945.0 in Q1 2024.
• Historically, Treasury Shares has averaged $842432.2 across 4 years, with a median of $327000.0 in 2022.
• The sharpest annual moves came in 2024 and 2025: Treasury Shares plunged 98.85% in 2024, then jumped 308.37% in 2025.
• A 4-year view of Treasury Shares shows it stood at $327000.0 in 2022, then changed by 0.0% to $327000.0 in 2023, then surged by 221.41% to $1.1 million in 2024, then surged by 308.37% to $4.3 million in 2025.
• The last three Treasury Shares figures came in at $4.3 million (Q4 2025), $1.1 million (Q4 2024), and $1.1 million (Q3 2024), per Business Quant data.